| Financial Year |
March 31 2023 |
| Monetary Funds |
92,950,679.19 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
53,716,565.45 |
| Accounts Receivable |
160,611,688.11 |
| Advances to Suppliers |
19,079,696.72 |
| Other Receivables |
8,701,640.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
218,804,909.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,736,018.24 |
| Total Current Assets |
589,193,580.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
7,925,986.44 |
| Fixed Assetes |
353,566,104.67 |
| Under-construction Projects |
17,178,094.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
123,872,146.16 |
| R&D expenses |
-- |
| Goodwill |
124,613,272.21 |
| Long-Term Deferred and Prepaid Expenses |
149,487.76 |
| Deferred Income Tax Assets |
820,496.50 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
628,343,876.52 |
| Total Assets |
1,217,537,457.39 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
66,402,916.33 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,772,734.68 |
| Taxes Payable |
2,750,438.34 |
| Interest Payable |
84,678.45 |
| Dividend Payable |
-- |
| Other payables |
86,144,859.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
39,097,551.68 |
| Other Current Liabilities |
45,310,467.12 |
| Sub-Total of Current Liabilities |
268,704,052.96 |
| Long-term Loans |
184,302,759.40 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
12,032,227.95 |
| Special Payable |
-- |
| Estimatied Liabilities |
6,237,162.14 |
| Deferred Income Tax Liabilities |
29,920.91 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
239,181,850.67 |
| Total Liabilities |
507,885,903.63 |
| Paid-In Capital(Or Share Stock) |
1,138,656,366.00 |
| Capital Surplus |
694,947,950.48 |
| Surplus Reserve |
9,390,005.14 |
| LESS:Treasury Stock |
1,137,726.10 |
| Undistributed Profits |
-1,199,260,660.62 |
| Minority Stockholder's Interest |
61,018,209.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
648,633,344.48 |
| Owner's Equity（Stockholder's Equity） |
709,651,553.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,217,537,457.39 |
